Related Experiment Video
Updated: Jun 22, 2026
12:27
Polyelectrolyte Complex for Heparin Binding Domain Osteogenic Growth Factor Delivery
Published on: August 22, 2016
[Experimental study on spinal fusion induced by hBMP-4 gene modified tissue engineered bone]
Zhao-Min Zheng1, Zhi-Yong Dong, Guan-Ming Kuang
1Department of Orthopedics, First Affiliated Hospital, Sun Yat-Sen University, Guangzhou 510080, China. zhengzm1@163.com
Zhonghua Wai Ke Za Zhi [Chinese Journal of Surgery]
|July 1, 2009
Summary
Human bone morphogenetic protein 4 (hBMP-4) gene-modified tissue-engineered bone grafts effectively enhance spinal fusion in rabbits, serving as a viable substitute for traditional autograft bone in spinal fusion surgery.
Area of Science:
- Biomaterials Science
- Regenerative Medicine
- Orthopedic Surgery
Context:
- Spinal fusion surgery aims to achieve bony union between vertebrae.
- Autograft bone is the gold standard but has limitations like donor site morbidity.
- Tissue-engineered bone grafts offer a promising alternative to autografts.
Purpose:
- To evaluate the efficacy of human bone morphogenetic protein 4 (hBMP-4) gene-modified tissue-engineered bone grafts in enhancing rabbit spinal fusion.
- To determine if hBMP-4 gene-modified grafts are a suitable substitute for autograft bone.
Summary:
- Rabbit bone marrow-derived mesenchymal stem cells (BMSCs) were genetically modified with AAV-hBMP-4 or AAV-EGFP.
- These modified cells, suspended in collagen sponges, were implanted in rabbit spinal fusion models.
- Fusion rates were assessed using radiography, CT scans, palpation, and histological examination at 12 weeks.
Impact:
- hBMP-4 gene-modified grafts demonstrated significantly higher bony fusion rates compared to EGFP-modified grafts.
- The efficacy of hBMP-4 grafts was comparable to autograft bone in promoting spinal fusion.
- This study supports the potential of hBMP-4 engineered bone grafts as an effective alternative to autografts in spinal fusion procedures.